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Abstract 
Calcium Phosphate cement has been the subject of intense investigation over the past few 
years. This study compares difference in biocompatibility between the three main phases of 
Ca-P, namely Hydroxyapatite, Dicalcium phosphate and β-Tricalcium phosphate. It 
involves composite preparation followed by cell test. Material parameters were 
stoichiometry (Hydroxyapatite with Ca-P ratio of 1.67, Dicalcium phosphate with Ca-P 
ratio of 1.0, β-Tricalcium phosphate with Ca-P ratio of 1.50) and crystallographic structure 
and arrangement. The Composites in concern were produced by mixing PVA (polyvinyl 
alcohol) and Ca-P in equal fraction. Cell test was performed for 24 h and 7 days. 
Biocompatibility analysis was performed both qualitatively and quantitatively. XRD, FTIR, 
SEM and TEM were used to analyse materials at various stages of the research. All calcium 
phosphate composites were biocompatible with cells. Hydroxyapatite ceramic expressed 
highest biocompatibility followed by Dicalcium phosphate and β-Tricalcium phosphate 
after 24 h cell test, whereas, after the 7-days test biocompatibility of Dicalcium phosphate 
was comparable to Hydroxyapatite. This study shows that Dicalcium phosphate is a better 
alternative to Hydroxyapatite, where biodegradation is crucial for patients’ recovery. 
Keywords: Hydroxyapatite, Dicalcium Phosphate, β-Tricalcium Phosphate, 
biocompatibility, sol-gel   
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1. Introduction 
Muscoskeletal disorder is the highest cause of morbidity and disability globally. Over the 
decades a variety of materials have been researched to fill bone defects. Ideally, synthetic 
materials should be, biocompatible
1
, show minimal fibrotic reaction
2
, remodel, support new 
bone formation
3
 and possess mechanical properties as high or better than those of cortical 
bones to be used as bone grafts
1, 4
. Synthetic materials may consist of metals, ceramics, 
polymers and composites
5, 6
. The broad range of materials can be explained by the fact that 
none of these materials unite the five essential criteria mentioned above. 
 Ceramics such as calcium phosphates (Ca-P), calcium sulphates and Bioglass
®
 are of interest 
as bone implants since  they closely resemble natural bone structure 
7, 8
. These ceramics are 
used individually or combined to mimic natural bones
9-12
. It has been reported that various Ca-
P such as Hydroxyapatite (HA)
13
, α and β-Tricalcium phosphates (α,β-TCP)10, octacalcium 
phosphates, tetra calcium phosphates
14
 and anhydrous Dicalcium phosphates (DCP)
15, 16
 are 
especially suitable as biomaterials as they closely resemble the inorganic phase of natural 
bones. However, different phases of Ca-P have varying effect on the growth of cells
17
. 
Therefore, it is vital to understand the influence of synthetic Ca-P on osteointegration.  
Natural bone is made up of non-stoichiometric HA (Ca10-x(HPO4)6-x(OH)2-x) which contains 
other ions. For long, synthetic HA and β-TCP have been discerned as some of the most 
important bone substitute materials
18, 19
.  While HA is seemingly an active bio-ceramic with the 
capacity to bond firmly to bone, it is not capable of dissolving in a physiological environment
20
. 
This blocks the formation of new bone, hindering the remodification process, resulting in poor 
local stability
10
. Similarly, the degradation of β-TCP has been reported as undeterminable as it 
dissolves 12.3 times faster than HA in acidic medium and 22.3 times faster in basic medium
21
. 
They differ not only in their composition and physical properties from each other and from 
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bone, but also in their rate of absorption
12, 22
. The scientific community is still looking for 
adequate bone graft substitutes despite 40 years of research.  
One of the main controlled biodegradable osteoconductive material is DCP.  DCP is soluble 
and gradually dissolves at the implant site, releasing calcium and phosphate ions into the 
biological medium, allowing new bone formation
21
.  
Bone scaffolds are required to provide biocompatibility and strength; however, inorganic 
materials fail to provide strength on their own. In order to overcome the mechanical weakness 
of inorganic material, a polymeric constituent is usually introduced to enrich strength of final 
materials
23
. Polyvinyl Alcohol (PVA) is a hydrophilic, synthetic semi-crystalline polymer, 
which is biocompatible, non-carcinogenic and one of the most commonly used polymers in 
biomedical applications
24-28
. Physical interaction of PVA with the surface of inorganic 
materials is possible without the incorporation of any chemical additives, as PVA has high 
concentration of hydroxyl pendent groups which can easily crosslink with the surface of the 
material’s hydroxyl group23. Although PVA is highly biocompatible, fewer researchers have 
paid close attention to the critical behaviour of cells in the presence of PVA while comparing 
the three main phases (HA, DCP, β-TCP) of Ca-P composites. Hence, it is critical to compare 
cell growth and response to the above mentioned composites and evaluate the science behind 
this difference.  
This paper discusses a bioactive concept on an optimum balance between three phases of Ca-P. 
The topics include: description of these materials in terms of their physicochemical and 
crystallographic properties; characterization of interface; effect of individual components on 
cell growth and why DCP is a better alternative than HA and β-TCP.  
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2. Materials and Methods 
2.1 Materials  
Calcium Acetate Ca(CH3COO)2  (C1000, Sigma, UK)  and Ammonium Phosphate 
(NH4)2HPO4 (215996, Sigma, UK) were used as starting materials to prepare the three phases 
of Ca-P. PVA ( Mw -70,000-100,000,  Sigma, UK)  was used as the binder. Sodium 
Hydroxide (NaOH) (S8045, Sigma, UK) was used to maintain pH. Distilled water was used 
throughout the experiments.  
2.2 Sol-Gel Precipitation Process 
Hydroxyapatite Preparation 
HA particles were synthesized by the wet sol-gel precipitation method. The synthesis process 
involved simultaneous addition of 0.1 M Ca(CH3COO)2 solution and 0.06 M (NH4)2HPO4 
solution in the reaction vessel. Ca/P ratio was maintained at 1.67. The solution was stirred at 
a constant rate of 400 rpm using magnetic stirrer while temperature was maintained at 40°C 
during reaction and aging. NaOH was added to maintain pH at 9.5 – 10. The solution was 
stirred vigorously for 1 h and was allowed to age for 24 h. The obtained white precipitate was 
filtered, dried in vacuum at 90°C for 24 h and crushed using mortar and pestle and stored at 
room temperature.   
Dicalcium Phosphate Preparation 
DCP was prepared by the addition of 0.1 M Ca (CH3COO)2  and 0.1 M (NH4)2HPO4  in 
reaction vessel. The solution was stirred at a constant rate of 400 rpm using magnetic stirrer 
while pH was maintained at 7 during reaction and aging time. The solution was stirred for 1 h 
and left to age for 24 h.  Thereafter, the solution was filtered and the precipitate was dried at 
60 °C for 2 h, 100° C for 24 h and 300° C for 2 h. The powder was then crushed to obtain 
uniform particle size using mortar and pestle and stored at room temperature.    
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β-Tricalcium Phosphate preparation 
β-TCP was prepared according to Stoia et al 20. In brief, 0.3 M Ca(CH3COO)2 and               
0.2 M  (NH4)2HPO4 were added to the reaction vessel simultaneously. This precipitated non-
stoichiometric HA which was stirred continuously using magnetic stirrer at the rate of 400 
rpm. pH was maintained between 9.5 – 10 using NaOH throughout precipitation and aging. 
The precipitate was left to age for 24 h and was filtered out and dried at 60 °C for 2 h and at 
105 ° C for 24 h. The dried powder was annealed at 1000° C for 8 h and crushed using mortar 
and pestle and stored at room temperature.   
2.3 Composite Preparation  
To prepare the composites, 20% PVA solution was produced. This was stable for a few 
weeks and was stored for later use.  
The composites were made by mixing Ca-P with 20%PVA solution. Different ratio 
combinations were tried to attain workability of the material and 1:1 ratio by weight was used 
for all sample preparations. The composites were hand mixed using spatula and were placed 
in aluminium moulds with the dimensions of 15mm (D) x 5 mm (H). For each material, a 
number of test samples were produced. Pressure was applied individually to each sample 
with a mechanical hand press for 5 minutes which was equivalent to 26 MPa. The mould with 
the samples was then placed at 40°C for 24 h to dry. After 24h the samples were removed 
from the mould and stored at room temperature. 
2.4 Sample Characterisation 
Electron Microscopy  
To investigate morphology and particle size of the powders, Transmission Electron 
Microscopy (TEM) analysis was performed using high resolution Transmission electron 
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microscope JEOL 1400 ( JEOL ltd, Japan). Small quantities of the precipitates were placed 
on the copper grid and were analysed at an accelerating voltage of 120 kV.  
Scanning Electron Microscopy (SEM) analysis was performed on 24 h cell test specimens 
and 7 day specimens. All the specimens were fixed and dehydrated using freeze drying in 
liquid nitrogen and placed in the EMITECH K750 freeze drier for 24 h. The samples were 
then mounted on conducting carbon stub and gold coated by EMITECH K550. SEM 
examinations were performed using 15 kV accelerating voltage in a JEOL JSM -5600LV 
scanning electron microscope (JEOL ltd, Japan). All the samples were investigated at various 
magnifications.  
2.5 XRD Analysis  
Phase analysis of the Ca-P powders was conducted using X-ray diffraction (XRD). A Phillips 
X-ray diffractometer using CuK α (λ=1.5418 Ǻ) radiation with X celerator detector was 
employed. The diffractometer was operated at 45 kV and 40mA at a 2 ϴ range of 10-80 ° 
using a step size of 0.03° and a 50 s exposure.  
2.6 FTIR Analysis 
Fourier Transform Infrared spectroscopy (FTIR) analysis was performed to determine the 
functional groups in the phosphates and carbonate substitutes in the powders. All the samples 
were ground in a mortar and pestle and analysis was performed using spectra recorded by 
Bruker alpha P FTIR spectrometer utilizing diamond ATR. Each spectrum was the result of 
16 accumulated scans at 4 cm
-1
 resolution.   
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3. Biocompatibility Test 
3.1 Specimen Preparation for Cell Test   
Before performing the cell tests, specimens were sterilized in a controlled environment. 
Detailed procedure is described elsewhere
29
. In brief, samples were placed in 99% absolute 
ethanol for 30 minutes and placed in sterile petri dishes before drying at 80°C for 2 h.  
3.2 Cell Culture  
Chinese Hamster Ovary (CHO) cells (supplied by the biomedical school, Plymouth 
University) were chosen because of their low cost and their quick response to implant 
materials. They were cultured in Ham’s F-12 medium supplemented with 2mM L-Glutamine 
and 10% fetal bovine serum in 100% relative humidified atmosphere at 37°C. Stock cultures 
of CHO cells were seeded in 25-cm
2 
cell culture flasks
 
at 1 - 2 x 10
6
 cells/ml of medium. Sub 
culture was carried out every 3 to 4 days.   
3.3 Cell Survival Studies  
Biocompatibility of the three materials was compared by performing 24 h cell test followed 
by 7 day cell test. Test was performed in triplicate. A static seeding method was used with 
500μl media. 24 h cell test was performed by seeding samples at 7.2x105cells/ml, and then 
placed in a 37
o
C incubator for 24 h at 100 % relative humidity. For the seven day cell test, 
same procedure was followed as mentioned above while nutrients were replenished every 48 
h. 
3.4 Quantitative Analysis 
A new protocol was conceived for the quantitative analysis of the samples. Each sample was 
analysed at 4 different areas and the average was used to compare cell viability. Quantitative 
analysis was performed by generating a random number and alphabet. A grid was drawn and 
the generated coordinates were employed as the area of interest to study the cell growth and 
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density for each sample (Figure 1). Any coordinates directly neighbouring a previously 
chosen one was ignored. All the samples were analysed at the chosen co-ordinates and SEM 
images were taken at various magnifications (70x, 800x, 1000x, 2000x). This protocol was 
followed to avoid human bias towards samples with higher or lower cell count.  Images taken 
at 800x magnification were utilized for the analysis. Cell coverage was calculated based on 
looking at the coordinates and ascertaining if there was biological material on them.  
Another grid with 100 coordinates was created and 20 coordinates were chosen in random. 
800x magnification images were used for this purpose. This was performed on all the four 
coordinates that were randomly selected previously. The results were then averaged to 
differentiate the cell growth between the different samples.  
4.  Results and Discussion  
 4.1 Microstructure of the Powders  
Physical Properties  
The importance on microstructure of Ca-P has been confirmed through the reports of many 
credible researchers
15, 16, 18
. This has led to the determination of the biocompatibility of 
various phases of Ca-P. Figure 2 compares the shapes and sizes of the crystals and 
composites. From the SEM observations of different composites, it is clearly noticed that 
crystal structure and arrangement vary significantly between three phases. HA crystals appear 
to be botryoidal or globular however, TEM observation of the powder reveals that they are 
short nano-rod like crystals with a size range between 90-200nm (Figure2a,b). DCP 
composite appears to be rectangular in SEM analysis as they are elongated, wide and flat than 
equant while TEM analysis of the powder shows that they are similar in shape to HA crystals 
but their size ranges between 193- 454 nm (figure 2c,d). β-TCP crystals appear to be globular 
with irregular shape in both TEM and SEM analysis (Figure 2e,f) . Their size is in 
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micrometre scale which ranges between 0.70 µm – 3.74 µm.  This immense difference in the 
size of crystals is due to the difference in annealing temperature of the three powders. 
4.2 XRD Analysis 
Microstructure of the powders were analysed to obtain their mineral composition. XRD 
patterns of synthesized powders are presented in figure 3. HA and DCP exhibit broad 
diffraction peaks indicating low crystallinity. Okazaki et al have stated that XRD patterns 
become sharper by increasing temperature which means that the crystallinity degree increases 
with temperature. This is observed in β-TCP powder where the peaks are sharp and narrow. 
The apatite phase forms peaks at 2ϴ of 25.92°, 31.8°, 32.20°, 32.93°. This pattern reveals 
that HA was either poorly crystalline or, more likely nanocrystalline as evidenced by the 
broad peaks. This pattern stands valid, as the results from the spectrum can be correlated with 
the TEM images which bear witness.  
HA is one of the initial components in all the three powders. Annealing DCP at 300 °C has 
also produced broad spectrum peaks. The sharp peaks in β-TCP are due to the coarsening of 
grains during sintering process.  
4.3 FTIR Measurements 
FTIR analysis was carried out to elucidate the presence of PVA in the blended 
nanocomposites and to analyse any complex structural changes that might have occurred due 
to blending. The interaction (hydrogen bonding) between PVA, HA, DCP and TCP in the 
final composites were also analysed. The representative FTIR absorption spectra of pure (HA, 
DCP,β-TCP) powders ,PVA and composites (PVA - HA, PVA - DCP, PVA – βTCP)is 
shown in figure 4 and summarized in Table 1. 
The results indicate that incorporation of PVA into powders causes the formation of 
predominant broad absorption band associated with OH stretching of PVA from 3278-3296 
cm
-1 
in all the composites. This result suggests the presence of strong hydrogen bonding in 
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the composites. In addition, the major absorption bands of PO4
3-
 stretching which appears 
within the rage of 1100 cm
-1 
to 500 cm
-1 
on all the powders have a shift which can be 
attributed to the interaction between the molecules of PVA and the Ca-P powders. 
Furthermore, the overall PVA crystallinity has decreased in composites which were clearly 
evidenced by the weakening of the crystalline band at 1138cm
-1
.  
FTIR spectrum of HA powder and composite shows the presence of most characteristic 
chemical groups OH
-
, PO4
3-
, CO3
2-
 as well as HPO4
2-
 groups that characterize non-
stoichiometric HA. PO4
3-
 group forms intensive peak at 560 and 600 cm
-1 
and at 1000 -1100 
cm
-1
. Absorbed water band is relatively wide, from 3500 to 2700 cm
-1
 (figure 4a,b).
 
CO3
2-
group forms weak peak at 875 cm
-1 
in the composite. Note that the band shape, width and 
intensity differ between the powder and Composite (figure 4a,c). Additional peaks can be 
seen at 1086cm
-1 
in the HA composite spectrum which could be due to the interaction with 
PVA. These spectra also demonstrate low crystallinity degree as they were not thermally 
treated. Transmittance peaks can be observed (at 1568, 1455, 1420 cm
-1
)
 
in the HA powder 
spectrum and (at 1418 cm
-1)
 in the HA composite spectrum for the presence of CO3
2-
. There 
is a decrease in the number of peaks and intensity in the final composite which confirms that 
there are fewer impurities. 
It is of interest to note that transmittance peak associated with P2O7 molecules distinctly 
appeared at 719 cm
-1 
and 727 cm
-1 
in the spectrum of DCP and β-TCP powders. Presence of 
DCP is confirmed by the P-O stretching modes between 900- 1200cm
-1 
and hydrogen bonded 
HPO4
2-
 ions are observed at 1387 cm-1. 
In the FTIR spectra of β-TCP, PO4
3- 
groups are observed which is characteristic to β-TCP. In 
addition, the presence of P2O7 group can be observed in both the powder and composite, 
which is characteristic to calcium pyrophosphate phase.  
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4.4 Biocompatibility Test  
When implanted in bone, Ca-P ceramics should provide cell anchorage sites and structural 
guidance to form new bone. To disclose the material’s functionality behind the camouflage of 
osteoinduction few types of Ca-P ceramics were tested with fibroblast cells. Cell tests were 
conducted for 24 h and 7days and at the end of the test period Ca-P composites with the cells 
were removed from the medium, freeze dried and observed in SEM for the presence of cells. 
Many fibroblasts were easily visible on all the specimens (figure 5). The cells were large (12-
14 µm) and showed well-defined margins and were clearly visible and easily distinguishable. 
However, their appearance differed on each material. SEM observation of the 24 h samples 
indicated presence of monolayer of cells. Cells on HA sample showed better cell growth 
followed by DCP and β-TCP. It can be seen from figure 5a that cells on HA samples are flat 
and expanding to make contact with nearby cells and had infiltrated through pores. Cells in 
DCP sample showed significant difference in morphology compared to HA counterpart. 
After 24h test, cells appeared to be circular with extending cellular material but were not flat 
like cells grown on HA samples (figure 5b). Of all the materials studied, β-TCP exhibited 
least compatibility (Figures 5c).  Subsequently, from figure 5d, it can be seen that 7 day 
samples showed presence of multilayer of cells. The cells were all interconnected and had 
created a coating on the sample. This also evidenced that PVA was bioactive.   
Whilst it is known that the size and shape of particles contribute to the bioactivity of the 
material, the chemical composition also plays a vital role 
30
. The presence of an additional 
OH group in HA is said to promote cell growth. However, after the 7 day test it can be seen 
from figure 5e that the growth of the cells in DCP sample are comparable to HA and they 
also have multilayer of cells. Hence it can be considered that over a period of time 
biocompatibility of the material is exhibited clearly and is comparable to HA.  
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In β-TCP sample the growth of cells is still limited (figure 5f). This could be due to the lack 
of OH ions in the material. Size of the cells was relatively small compared to cells in the 
other two materials. Furthermore, a trend has been observed that better biocompatibility is 
exhibited in HA which is made of small particles followed by DCP and β-TCP. Another 
contributing factor could be the nonexistence of pores. It is well known that cells thrive in 
materials with a maximum pore size of 100µm. Both HA and DCP materials exhibited pores 
in the range of 50-60 µm however, no pores were visible in β-TCP composite.  
Quantitative analysis (figure 6) of the samples after 24 h and 7 day also revealed that HA had 
highest growth of cells while β-TCP had the least. Results were significant at p=0.05 level at 
both tests. 1 day t-test yielded t values of 9.95 for β-TCP and 3.05 for DCP. The t test results 
for 7 day cell study was t=14.2 for β-TCP and t-4.07 for DCP. The coverage and uniform 
spread of cells on the surface are important as the cellular distribution across the entire 
scaffold has great effect on overall sustainability. Therefore area coverage has been used to 
measure the biocompatibility of the materials. However, it can be observed in 7 day cell test 
that multilayer of cells have developed unlike 24 h sample where only monolayer of cells is 
observed.  
Quantitative analysis confirmed that β-TCP had the lowest growth of fibroblast cells 
indicating low bioactivity. This was confirmed on both cell tests where β-TCP samples had 
low presence of cellular material compared to HA.  
5. Conclusion 
Ca-P synthesis methods and their technological parameters can significantly impact 
stoichiometry of the product, its grade of crystallization, particle size, bio-ceramic phase 
composition, thermal stability, microstructure and mechanical properties. The important 
technological parameters that impact properties of Ca-P synthesis product and also of bio-
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ceramic are temperature of synthesis, pH of synthesis environment, reagent type and 
concentration as well as selection of raw materials and their purity and quality. All of the 
above mentioned also brings a significant impact on tissue response of these bio- ceramic 
implants. 
The study was performed to observe the outcome of cell response on various phases of Ca-P.  
DCP was produced to evaluate its osteoinduction properties against HA and β-TCP. PVA 
was used to make the composites owing to its bioactive properties. All the specimens were 
tested with CHO cells for 24 h and 7days to identify growth pattern and cell response. It is 
found that, HA showed better biocompatibility however, its inability to be reabsorbed to give 
way for the development of new bone is considered a disadvantage. Similarly, β-TCP did not 
exhibit biocompatibility to the standard of HA but its ability to resorb is highly appreciable. 
DCP showed improved cell adhesion over the period of 7 days and was comparable to that of 
HA. Hence, the findings conclude that DCP would be an ideal bone graft material as it is 
resorbable and cell study has shown significant improvement after the 7 day study.  
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Figure 1. Model depicting the area of interest for quantitative analysis. The squares 
marked in red represent the area that was used for quantitative analysis using the SEM 
image.  
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Figure 2. Microstructure analysis of Ca-P Powers and composites. a) SEM analysis of HA 
composite. b)TEM analysis of HA powders. c) SEM analysis of DCP. d)TEM analysis of 
DCP. e) SEM analysis of β-TCP powder. f) TEM analysis of β-TCP composite.   
 
 
a b 
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e f 
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 Figure 3.  XRD analysis of HA, DCP, β-TCP 
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Figure 4. a, b -FTIR spectra for HA, DCP and TCP powders. c- FTIR spectra for HA/PVA, 
DCP/PVA, β-TCP/PVA composites and PVA
a 
b 
c 
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Table 1.  Assignment of FTIR Absorption Bands of Pure Powders and Composites  
Peaks for Powder ( cm
-1
)   Peaks for composites( cm
-1
)      Assignment  
HA   DCP        TCP      PVA     HA/PVA DCP/PVA βTCP/PVA 
 
3361            Stretching and bending mode of H2O (Water) 
                      3266   3283  3284      3287                  Stretching of OH 
       2937          Asymmetric stretching of CH2 
                       2907  2909  2912      Asymmetric stretching of CH2  
      2323       2069    P-O 
1646 1639         1656    1647      O=H, C=C   
1568          1565        O=H,C=C 
1455 1400         1428          Impurities (CO2
3-
) 
1420            Impurities (CO2
3-
) 
          1417   1418       1427    O-H,C-H bending, γ(CH2),δ(OH) 
          1325  1344      δ(OH)with CH wagging 
          1237        C-O-C 
        1214         1215    Symmetric stretching of PO4
3-
  
          1138         Stretching of CO (crystalline sequence of PVA) 
 1136       1118    1126     1117    Symmetric stretching of PO4
3-  
1088                                                                                                 Stretching of CC and bending of OH (amorphous sequence of PVA) 
1021 1068       1007                      1086  1060     Symmetric stretching of PO4
3- 
 
1032       1024      1024     1024    Symmetric stretching of PO4
3- 
 
1000       1005          Symmetric stretching of PO4
3- 
962         977,947        981,962     992,889     972    stretching of HPO4
2- 
875 924           Stretching of  P-O-H  
           917        Bending of CH2 
           841,840       Rocking of CH2 
  719       727        728    Stretching of P2O
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Figure 5.  SEM analysis of biocompatibility test. a,b,c -24h cell test result of HA,DCP and β-
TCP respectively. d,e,f- seven day cell test results of HA, DCP and β-TCP respectively.   
  
c 
f e 
d 
a b 
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Figure 6.Quantitative analysis of biocompatibility. a - Coverage of samples by cells after 
24 h. b - Coverage of samples by cells after seven days.  
 
 
 
 
 
 
 
 
b 
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